Shanghai Haoyuan Chemexpress Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shanghai Haoyuan Pharmaceutical Co., Ltd. (stock code:, Build an integrated service platform for drug research and development and production of "starting materials intermediates raw materials formulations", accelerate the empowerment of global partners to achieve the entire process from preclinical to commercial production, make drug research and development more efficient, faster to market, and benefit human health earlier. After 16 years of development, the company has established deep cooperative relationships with well-known pharmaceutical enterprises, research institutes, and CRO companies in multiple regions such as Asia, Europe, the Americas, and Oceania. It carries research and development innovation projects from more than 6000 partners worldwide, and has been rated as a high-tech enterprise, a national level specialized and innovative "little giant" enterprise, a Shanghai brand cultivation demonstration enterprise, and a Shanghai enterprise technology center, Received multiple honorary titles such as the 2021 Top 20 CDMO Enterprises in China and the 2021 Top 500 New Economy Enterprises in China. In the future, the company will continue to focus on the development strategy of "industrialization, globalization, and branding", adhere to the service tenet of "everything for customers, everything comes from innovation", deeply cultivate the research and development services and industrial application market of small molecule and new molecule drugs, create an internationally competitive and world-class pharmaceutical research and development and production service enterprise, and promote research and development innovation to improve the survival status and quality of life of patients worldwide. |
| Headquarter | Shanghai |
| Establish Date | 9/30/2006 |
| Listed Code | 688131.SH |
| Listed Date | 6/8/2021 |
| Chairman | Zheng Baofu. |
| CEO | Zheng Baofu. |
| Website | www.chemexpress.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
